Literature DB >> 18201696

Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.

Yasuji Mori1, Monique Hinchcliff, Minghua Wu, Matthew Warner-Blankenship, Karen M Lyons, John Varga.   

Abstract

BACKGROUND: The matricellular protein connective tissue growth factor (CCN2) has been implicated in pathological fibrosis, but its physiologic role remains elusive. In vitro, transforming growth factor-beta (TGF-beta) induces CCN2 expression in mesenchymal cells. Because CCN2 can enhance profibrotic responses elicited by TGF-beta, it has been proposed that CCN2 functions as an essential downstream signaling mediator for TGF-beta. To explore this notion, we characterized TGF-beta-induced activation of fibroblasts from CCN2-null (CCN2(-/-)) mouse embryos.
METHODS: The regulation of CCN2 expression was examined in vivo in a model of fibrosis induced by bleomycin. Cellular TGF-beta signal transduction and regulation of collagen gene expression were examined in CCN2(-/-) MEFs by immunohistochemistry, Northern, Western and RT-PCR analysis, immunocytochemistry and transient transfection assays.
RESULTS: Bleomycin-induced skin fibrosis in the mouse was associated with substantial CCN2 up-regulation in lesional fibroblasts. Whereas in vitro proliferation rate of CCN2(-/-) MEFs was markedly reduced compared to wild type MEFs, TGF-beta-induced activation of the Smad pathways, including Smad2 phosphorylation, Smad2/3 and Smad4 nuclear accumulation and Smad-dependent transcriptional responses, were unaffected by loss of CCN2. The stimulation of COL1A2 and fibronectin mRNA expression and promoter activity, and of corresponding protein levels, showed comparable time and dose-response in wild type and CCN2(-/-) MEFs, whereas stimulation of alpha smooth muscle actin and myofibroblast transdifferentiation showed subtle impairment in MEFs lacking CCN2.
CONCLUSION: Whereas endogenous CCN2 plays a role in regulation of proliferation and TGF-beta-induced myofibroblast transdifferentiation, it appears to be dispensable for Smad-dependent stimulation of collagen and extracellular matrix synthesis in murine embryonic fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18201696      PMCID: PMC3963386          DOI: 10.1016/j.yexcr.2007.12.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

Review 1.  Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.

Authors:  Sergio A Jimenez; Chris T Derk
Journal:  Ann Intern Med       Date:  2004-01-06       Impact factor: 25.391

2.  Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.

Authors:  S J Chen; W Yuan; S Lo; M Trojanowska; J Varga
Journal:  J Cell Physiol       Date:  2000-06       Impact factor: 6.384

3.  Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression.

Authors:  Biao Hu; Zhe Wu; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-17       Impact factor: 6.914

4.  Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.

Authors:  Y Mori; S J Chen; J Varga
Journal:  Exp Cell Res       Date:  2000-08-01       Impact factor: 3.905

5.  Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.

Authors:  A C Poncelet; H W Schnaper
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

6.  The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.

Authors:  C C Chen; N Chen; L F Lau
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

7.  Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.

Authors:  Shinsuke Takagawa; Gabriella Lakos; Yasuji Mori; Toshiyuki Yamamoto; Kiyoshi Nishioka; John Varga
Journal:  J Invest Dermatol       Date:  2003-07       Impact factor: 8.551

8.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.

Authors:  Sanja Ivkovic; Byeong S Yoon; Steven N Popoff; Fayez F Safadi; Diana E Libuda; Robert C Stephenson; Aaron Daluiski; Karen M Lyons
Journal:  Development       Date:  2003-06       Impact factor: 6.868

9.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

Authors:  José G Abreu; Nan I Ketpura; Bruno Reversade; E M De Robertis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

10.  Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.

Authors:  Elizabeth Gore-Hyer; Jaspreet Pannu; Edwin A Smith; Gary Grotendorst; Maria Trojanowska
Journal:  Arthritis Rheum       Date:  2003-03
View more
  21 in total

Review 1.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  CCN2: a bona fide target for anti-fibrotic drug intervention.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-03-06       Impact factor: 5.782

3.  Possible strategies for anti-fibrotic drug intervention in scleroderma.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-01-29       Impact factor: 5.782

Review 4.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

Review 5.  Molecular pathogenesis of skin fibrosis: insight from animal models.

Authors:  Gideon P Smith; Edwin S L Chan
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

6.  Targeting myosin 1c inhibits murine hepatic fibrogenesis.

Authors:  Ehtesham Arif; Cindy Wang; Marzena K Swiderska-Syn; Ashish K Solanki; Bushra Rahman; Paul P Manka; Jason D Coombes; Ali Canbay; Salvatore Papa; Deepak Nihalani; Patricia Aspichueta; Joshua H Lipschutz; Wing-Kin Syn
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-04-28       Impact factor: 4.052

7.  Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Authors:  Flavia V Castelino; Jon Seiders; Gretchen Bain; Sarah F Brooks; Christopher D King; James S Swaney; Daniel S Lorrain; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Arthritis Rheum       Date:  2011-05

Review 8.  In perspective: murine models of scleroderma.

Authors:  Minghua Wu; John Varga
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

9.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

10.  A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.

Authors:  S Bhattacharyya; W Ishida; M Wu; M Wilkes; Y Mori; M Hinchcliff; E Leof; J Varga
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.